Literature DB >> 17083528

Intravitreal steroids in the management of macular oedema.

Sobha Sivaprasad1, Peter McCluskey, Susan Lightman.   

Abstract

The use of intravitreal corticosteroids in the management of macular oedema has recently gained widespread acceptance. New long-acting steroid preparations and methods of delivery have facilitated the use of these new modalities. This review describes the various types of macular oedema for which this therapeutic option is used and the results.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17083528     DOI： 10.1111/j.1600-0420.2006.00698.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN： 1395-3907


  16 in total

1.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

Review 2.  Non-infectious pediatric uveitis: an update on immunomodulatory management.

Authors:  Srilakshmi M Sharma; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

3.  Optimization of dexamethasone mixed nanomicellar formulation.

Authors:  Kishore Cholkar; Sudharshan Hariharan; Sriram Gunda; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

4.  Compared antioxidant activity among corticosteroids on cultured retinal pigment epithelial cells.

Authors:  Nuzzi Raffaele; Alessandro Marchese; Dario Ghigo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-14       Impact factor: 3.117

5.  Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.

Authors:  Chengyun Wang; Huiyuan Hou; Kaihui Nan; Michael J Sailor; William R Freeman; Lingyun Cheng
Journal:  Exp Eye Res       Date:  2014-11-05       Impact factor: 3.467

6.  Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone.

Authors:  M Selim Kocabora; Cemil Yilmazli; Muhittin Taskapili; Gokhan Gulkilik; Sahan Durmaz
Journal:  Clin Ophthalmol       Date:  2008-03

7.  Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%.

Authors:  Seenu M Hariprasad; Levent Akduman; Joseph A Clever; Michael Ober; Franco M Recchia; William F Mieler
Journal:  Clin Ophthalmol       Date:  2009-06-02

8.  Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution.

Authors:  Hyung Cho; Kenneth J Wolf; Eric J Wolf
Journal:  Clin Ophthalmol       Date:  2009-06-02

9.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008

10.  Diabetic macular edema.

Authors:  Einar Stefánsson
Journal:  Saudi J Ophthalmol       Date:  2009-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.